Biopharma

FDA Warns Consumers Not to Use Counterfeit Ozempic (sem...

Audience: Consumers April 14, 2025 -- FDA was notified by Novo Nordisk on April ...

Novo Nordisk Warns Consumers About Counterfeit Ozempic ...

PLAINSBORO, N.J., April 14, 2025 /PRNewswire/ -- Novo Nordisk has become aware o...

FDA Grants Interchangeable Designation to Yuflyma (adal...

INCHEON, South Korea, April 14, 2025 /-- Celltrion, Inc. today announced that th...

FDA Approves Jobevne (bevacizumab-nwgd), a Biosimilar t...

BRIDGEWATER, New Jersey and BENGALURU, Karnataka, India, April 10, 2025 -- Bioco...

Mirum’s Livmarli Now FDA Approved in Tablet Formulation

FOSTER CITY, Calif.--(BUSINESS WIRE) April 14, 2025 -- Mirum Pharmaceuticals, I...

STAT+: Attorneys general want Congress to prohibit PBMs...

State AGs are concerned about conflicts of interest that allow PBMs to dominate ...

US launches probe that could set stage for pharma tariffs

The Commerce Department has begun a so-called Section 232 investigation into the...

Ironwood Pharmaceuticals Provides Clinical and Regulato...

BOSTON--(BUSINESS WIRE) April 14, 2025 -- Ironwood Pharmaceuticals, Inc. (Nasda...

STAT+: Trump administration launches probe into pharmac...

The Trump administration disclosed that it had formally opened an investigation ...

Hurricanes, Pandemic Led to Drop in CRC Incidence in Pu...

MONDAY, April 14, 2025 -- Recent major events, including hurricanes Irma and Ma...

FDA Approves Opdivo (nivolumab) + Yervoy (ipilimumab) a...

PRINCETON, N.J.--(BUSINESS WIRE) April 11, 2025 -- Bristol Myers Squibb (NYSE: ...

'One of the lucky few': Bicara's CEO on operating in to...

Amid an FDA overhaul and market volatility, one biotech executive says her publi...

Pfizer Discontinues Development of Oral GLP-1 Receptor ...

NEW YORK--(BUSINESS WIRE) April 14, 2025 -- Pfizer Inc. (NYSE: PFE) today announ...

Amgen bumps up pay for longtime CEO Robert Bradway 8% t...

Amgen CEO Robert Bradway scored $24.4 million in total compensation last year, h...

Market volatility compounds 'already challenging' year ...

The market turbulence unleashed by President Donald Trump’s tariff policies will...

Aurobindo gets Form 483 scolding from FDA at North Caro...

Aurobindo's Aurolife Pharma has received a Form 483 from the FDA outlining 11 ob...

UK launches one-year rollout of clinical trial regulati...

The U.K. is rolling out new regulations meant to reduce red tape for clinical st...

UK launches 1-year rollout of clinical trial regulation...

The U.K. is rolling out new regulations meant to reduce red tape for clinical st...

STAT+: An interview with Christi Grimm, and ‘existentia...

This week in health care news: An interview with the fired HHS watchdog, inside ...

STAT+: Canada advances an antitrust probe into Express ...

Canadian officials have obtained a court order that requires Express Scripts to ...

Safety worries spur Pfizer to drop another obesity pill

Signs of potential liver damage in a study participant led the company to abando...

RFK Jr. blasts FDA as industry's 'sock puppet,' warns a...

In a Friday speech to FDA employees, the HHS secretary laid bare his belief that...

Third Harmonic outlines plans for dissolution

The Atlas-backed company plans to liquidate its assets, including an experimenta...

Human medicines European public assessment report (EPAR...

Human medicines European public assessment report (EPAR): Capvaxive, pneumococca...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.